Export 2632 results:
Author Title Type [ Year(Asc)]
2021
A. D. Williams, Kanner, J., Grantz, K. L., Ouidir, M., Sheehy, S., Sherman, S., Robledo, C., and Mendola, P., “Air pollution exposure and risk of adverse obstetric and neonatal outcomes among women with type 1 diabetes.”, Environ Res, vol. 197, p. 111152, 2021.
R. N. Khurana, Oden, N. L., VanVeldhuisen, P. C., Scott, I. U., Blodi, B. A., and Ip, M. S., “Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents : SCORE2 report 12: secondary analysis of the SCORE2 clinical trial.”, Graefes Arch Clin Exp Ophthalmol, 2021.
M. C. H. Rohn, Stevens, D. R., Kanner, J., Nobles, C., Chen, Z., Grantz, K. L., Sherman, S., Grobman, W. A., Kumar, R., Biggio, J., and Mendola, P., “Asthma Medication Regimens in Pregnancy: Longitudinal Changes in Asthma Status.”, Am J Perinatol, 2021.
G. M. O’Kane, JL, S., P, K., RA, G., E, M. W., D, T., M, J., ER, M. A., ER, M. A., A, M., L, W., and J, P., “BOLD-100-001 (TRIO039): A phase Ib Dose-escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Gastrointestinal Solid Tumors”, in ASCO Annual Meeting, 2021.
L. - T. Wu, John, W. S., Ghitza, U. E., Wahle, A., Matthews, A. G., Lewis, M., Hart, B., Hubbard, Z., Bowlby, L. A., Greenblatt, L. H., and Mannelli, P., “Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.”, Addiction, 2021.
M. H. Trivedi, Walker, R., Ling, W., Cruz, Adela, Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., Sparenborg, S., and Coffin, P., “Bupropion and Naltrexone in Methamphetamine Use Disorder”. 2021.
J. Kanner, Pollack, A. Z., Ranasinghe, S., Stevens, D. R., Nobles, C., Rohn, M. C. H., Sherman, S., and Mendola, P., “Chronic Exposure to Air Pollution and Risk of Mental Health Disorders Complicating Pregnancy.”, Environ Res, p. 110937, 2021.
J. McNeely, Adam, A., Rotrosen, J., Wakeman, S. E., Wilens, T. E., Kannry, J., Rosenthal, R. N., Wahle, A., Pitts, S., Farkas, S., Rosa, C., Peccoralo, L., Waite, E., Vega, A., Kent, J., Craven, C. K., Kaminski, T. A., Firmin, E., Isenberg, B., Harris, M., Kushniruk, A., and Hamilton, L., “Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics.”, JAMA Netw Open, vol. 4, no. 5, p. e2110721, 2021.
S. Lanzkron, “Cure Sickle Cell Initiative Standardized Data Forms for Genetic Therapy Studies”, 2021.
S. Lanzkron, Thompson, A., Mondoro, T., Carroll, P., DeBaun, M., Kanter, J., Malik, P., Manwani, D., Pierciey, J., Walters, M., Clemons, T., Coleman-Cowger, V., and Alai, S., “Cure Sickle Cell Initiative Standardized Data Forms for Genetic Therapy Studies”, in American Society of Gene and Cell Therapy, Virtual, 2021.
G. D'Onofrio, Hawk, K. F., Herring, A. A., Perrone, J., Cowan, E., McCormack, R. P., Dziura, J., R Taylor, A., Coupet, E., E Edelman, J., Pantalon, M. V., Owens, P. H., Martel, S. H., O'Connor, P. G., Van Veldhuisen, P., DeVogel, N., Huntley, K., Murphy, S. M., Lofwall, M. R., Walsh, S. L., and Fiellin, D. A., “The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation.”, Contemp Clin Trials, vol. 104, p. 106359, 2021.
E. Agrón, Mares, J., Clemons, T. E., Swaroop, A., Chew, E. Y., and Keenan, T., “Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.”, Ophthalmology, vol. 128, no. 3, pp. 425-442, 2021.
T. Etheridge, Dobson, E. T. A., Wiedenmann, M., Oden, N., VanVeldhuisen, P., Scott, I. U., Ip, M. S., Eliceiri, K. W., Blodi, B. A., and Domalpally, A., “Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14.”, Transl Vis Sci Technol, vol. 10, no. 3, p. 31, 2021.
E. Ertin, Sugavanam, N., Holtyn, A. F., Preston, K. L., Bertz, J. W., Marsch, L. A., McLeman, B., Shmueli-Blumberg, D., Collins, J., King, J. S., McCormack, J., and Ghitza, U. E., “An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches”, Front Psychiatry, vol. 12, p. 674691, 2021.
L. Pauleikhoff, Heeren, T. F. C., Gliem, M., Lim, E., Pauleikhoff, D., Holz, F. G., Clemons, T., Balaskas, K., Egan, C. A., and Issa, P. Charbel, “Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.”, Am J Ophthalmol, vol. 228, pp. 27-34, 2021.
R. Bonelli, Ansell, B. R. E., Lotta, L., Scerri, T., Clemons, T. E., Leung, I., Peto, T., Bird, A. C., Sallo, F. B., Langenberg, C., and Bahlo, M., “Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression.”, Genome Med, vol. 13, no. 1, p. 39, 2021.
S. Morgello, Cortes, E. P., Gensler, G., Meloni, G., Jacobs, M. M., Murray, J., Borukov, V., and Crary, J. F., “HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition.”, AIDS, 2021.
S. E. Frey, Stapleton, J. T., Ballas, Z. K., Rasmussen, W. L., Kaufman, T. M., Blevins, T., Jensen, T. L., D Davies, H., Tary-Lehman, M., Chaplin, P., Hill, H., and Goll, J. B., “Human antibody responses following vaccinia immunization using protein microarrays and correlation with cell-mediated and antibody dependent cellular cytotoxicity responses.”, J Infect Dis, 2021.
S. Sivapalasingam, Saviolakis, G. A., Kulcsar, K., Nakamura, A., Conrad, T., Hassanein, M., Sumner, G., Elango, C., Kamal, M. A., Eng, S., Kyratsous, C. A., Musser, B. J., Frieman, M., Kantrowitz, J., Weinreich, D. M., Yancopoulos, G., Stahl, N., and Lipsich, L., “Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV).”, J Infect Dis, 2021.
P. Winokur, Sahly, H. M. El, Mulligan, M. J., Frey, S. E., Rupp, R., Anderson, E. J., Edwards, K. M., Bernstein, D. I., Schmader, K., Jackson, L. A., Chen, W. H., Hill, H., and Bellamy, A., “Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.”, Vaccine, vol. S0264-410X, no. 20, pp. 31504-31508, 2021.
M. Shahait, Liu, V. Y. T., Vapiwala, N., Lal, P., Kim, J., Trabulsi, E. J., Huang, H. - C., Davicioni, E., Thompson, D. J. S., Spratt, D., Den, R. B., and Lee, D. I., “Impact of Decipher on use of post-operative radiotherapy: Individual patient analysis of two prospective registries.”, BJUI Compass, 2021.
M. E. Horwitz, tiff, P., Rezvani, A. R., Hwang, W. Ying Khee, Karras, N., Valcarcel, D., Koh, L. Piu, yasser, K., Keating, A. K., Segalovich, I., Sanz, G., Cutler, C., Brunstein, C. G., Hanna, R., McGuirk, J. P., Lindemans, C. A., Maziarz, R. T., Schiller, G. J., Hammerschlak, N., Frankfurt, O., Blackwell, B., and Galamidi, E., “Improved Clinical Outcomes with Omidubicel versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized, Multicenter Study”. 2021.
D. A. J. Friedman-Klabanoff, Berry, A. A., Travassos, M. A., Cox, C., Zhou, Y., Mo, A. X., Nomicos, E. Y. H., Deye, G. A., Pasetti, M. F., and Laurens, M. B., “Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing.”, Vaccine, vol. S0264-410X(20)31590, 2021.
A. M. Denicoff, S. Ivy, P., Worthington, K. H., Zhao, J., Seibel, N., Mishkin, G. E., Mooney, M. M., and Little, R. F., “National Cancer Institute (NCI) implementation of the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) broadening clinical trials eligibility criteria”, ASCO Annual Meeting 2021. 2021.
S. R. Morris, Bristow, C. C., Wierzbicki, M. R., Sarno, M., Asbel, L., French, A., Gaydos, C. A., Hazan, L., Mena, L., Madhivanan, P., Philip, S., Schwartz, S., Brown, C., Styers, D., Waymer, T., and Klausner, J. D., “Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study.”, Lancet Infect Dis, vol. 21, no. 5, pp. 668-676, 2021.